Imetelstat improves patient-reported outcomes and quality of life in lower-risk myelodysplastic syndromes: results from the phase III IMerge study

Red blood cell (RBC) transfusions for anemia associated with lower-risk myelodysplastic syndromes/neoplasms (LR-MDS) often contribute to reduced quality of life (QOL). Thus, reduction in RBC transfusion dependency (TD) is a primary therapeutic goal. Imetelstat is a firstin-class, competitive telome...

पूर्ण विवरण

ग्रंथसूची विवरण

मुख्य लेखकों:	Mikkael A. Sekeres, Amer M. Zeidan, Valeria Santini, Rami S. Komrokji, Pierre Fenaux, Michael R. Savona, Yazan F. Madanat, David Valcárcel, Antoine Regnault, Kristin Creel, Libo Sun, Ying Wan, Shyamala Navada, Tymara Berry, Faye Feller, Uwe Platzbecker, María Díez-Campelo, Esther Natalie Oliva
स्वरूप:	Artigo
भाषा:	Inglês
प्रकाशित:	Ferrata Storti Foundation 2026-01-01
श्रृंखला:	Haematologica
ऑनलाइन पहुंच:	https://haematologica.org/article/view/13107
टैग:	टैग जोड़ें कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!